Efficacy and safety of rituximab in the treatment of good prognosis microscopic polyangiitis
Efficacy and safety of rituximab in the treatment of good prognosis microscopic polyangiitis - RITUXGOPRO Efficacy and safety of rituximab in the treatment of good prognosis microscopic polyangiitis - RITUX ...
Patients with newly diagnosed or relapsing MPA, without any poor prognosis marker (FFS=0). Stratification will be made according to peripheral nerve involvement. MedDRA version: 20.0;Level: PT;Classification code 10063344;Term: Microscopic polyangiitis;System Organ Class: 10047065 - Vascular disorders ;Therapeutic area: Diseases [C] - Immune System Diseases [C20] Patients with newly diagnosed or relapsing MPA, without any poor prognosis marker (FFS=0). Stratific ...
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): yes Therapeutic use (Phase 4): no Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...